PATENT CLAIM ANALYSIS

Application Number: 16209326
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-03
Patent Classification: ["424", "001110"]

Abstract:
An anti-IL-12 antibody or fragment thereof that binds to a portion of the IL-12 protein corresponding to at least one amino acid residue selected from the group consisting of residues 15, 17-21, 23, 40-43, 45-47, 54-56 and 58-62 of the amino acid sequence of the p40 subunit of IL-12, including isolated nucleic acids that encode at least one anti-IL-12 antibody or fragment thereof, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.

Claim (Index 10):
The host cell according to  claim 9 , wherein said host cell is at least one selected from COS-1, COS-7, HEK293, BHK21, CHO, BSC-1, Hep G2, 653, SP2/0, 293, HeLa, myeloma, or lymphoma cells, or any derivative, immortalized or transformed cell thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.59677
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11722312', '15217099', '13299831', '14512757', '13669894']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.739912393716414
- 35 USC 102 Novelty (BERT): 0.5239598648646558
- Combined Prediction Score: 0.7183171408312382
- Mean Citation Score: 308.791894
- Max Citation Score: 322.6307
- Similarity Product: 267.42959985082746

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test